BNET Industries

Market Cap:$117.7M
Last Fiscal Year Sales:$46.6M
  • Public
  • US
Dow Jones Description

SenoRx was founded in 1998 to design, develop, manufacture and market minimally invasive devices for the diagnosis and treatment of breast cancer. SenoRx (NASDAQ: SENO) completed its initial public offering of common stock in March 2007. Since its founding, SenoRx has developed multiple, proprietary technology platforms and a unique product portfolio that address a range of diagnostic and therapeutic procedures. These products include the EnCor vacuum-assisted breast biopsy system, the Contura Multi-Lumen Balloon (MLB) applicator for delivering radiation to the tissue surrounding the lumpectomy cavity following surgery for breast cancer, and SenoSonix, which combines ultrasound and vacuum assisted biopsy in one system. It is the goal of SenoRx to become the leader in the breast care market by offering products that dramatically enhance patient outcomes. SenoRx has placed thousands of its products in breast centers, hospitals, outpatient centers, and radiation oncology centers across the United States and Canada, and around the world. SenoRx's field sales organization serves over 2,000 breast diagnostic and treatment centers in the United States and Canada. In addition, SenoRx sells several of its products through distribution partners in more than 30 countries outside the U.S. and Canada. The company's line of breast care products includes biopsy disposables, biopsy capital equipment, diagnostic adjunct products and therapeutic disposables. ...

President, Chief Executive Officer and Director
Lloyd H. Malchow
Number of Employees 155
Contact Information

3 Morgan

Irvine, California 92618

senorx.com

(949) 362-4800

NAICS Code Surgical and Medical Instrument Manufacturing: 339112

Recent Events

  • SenoRx Narrows Guidance

    11/03/09 - Financial Announcement - View Story

  • xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts October 27, 2009 : SENO, URRE, FBMI and COIN

    10/27/09 - Mgmt. Change Entering - President - View Story

  • SenoRx Announces Revised Court Schedule in Pending Hologic v. SenoRx Litigation

    10/09/09 - Bond / Stock Rating - View Story

  • SenoRx Cash Flow Positive in the Second Quarter and First Half of 2009 With Record...

    8/03/09 - Financial Announcement - View Story

  • Analyst Upgrades for July 16th

    7/16/09 - Bond / Stock Rating - View Story

News & Analysis

senorx inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Lloyd H. Malchow President, Chief Executive Officer and Director
John T Buhler Senior Vice President and Chief Commercial Officer
Kevin J. Cousins Vice President, Finance and Cfo
Paul Lubock Senior Vice President and Chief Technology Officer
Eben S. Gordon Vice President, Regulatory Affairs & Quality Assurance
Stephen H. Featherstone Vice President of Manufacturing
William F. Gearhart Vice President, Sales and Marketing
John E. Merritt Director, Manufacturing Engineering
Lila Churney Director of Investor Relations
Brian H Dovey
James C Blair
Karen Vallejo
Kathleen K Schoemaker
Steve Harrison Parker

Board of Directors

Name (plus bio) Position
Gregory D. Waller Chairman
A. Thomas Bender Board of Directors
Fred Dotzler Board of Directors
Frederick J. Dotzler Board of Directors
Fredrick Dotzler Board of Directors
John L Erb Board of Directors
Kim D. Blickenstaff Board of Directors
Kurt C. Wheeler Board of Directors
Vickie L. Capps Board of Directors
Wende S. Hutton Board of Directors

Organization Position Status
Senorx, Inc. President, Chief Executive Officer and Director Current
Senorx, Inc. Board of Directors Current
Pepperdine University M.B.A. Former
University of Maryland M.A. In Public Opinion Research Former
Carroll College B.A. In Government and Communication Former

John T. Buhler . Mr. Buhler has served as our Senior Vice President and Chief Commercial Officer since April 2009. From May 2008 to October 2008, he served as our Vice President of International Sales and Business Development and from October 2008 until April 2009 he served as our Vice President of Global Sales and Business Development. From August 2005 to May 2008, Mr. Buhler served as President and Chief Executive Officer at Ultrasonix Medical Corporation, a privately held manufacturer of high-quality diagnostic ultrasound imaging equipment. >From 1998 to 2005, Mr. Buhler held various positions at General Electric, last serving as Vice President and General Manager of GE's Ultrasound Performance Technologies Division. Prior to 1998, Mr. Buhler held various positions with Diasonics Inc., a global medical imaging device manufacturer, last serving as Vice President of Operations. Mr. Buhler earned his B.S. in Business Administration and Human Resources at Dominican College, Blauvelt, New York, and is completing the M.B.A. program at the University of Wisconsin, Milwaukee.

Organization Position Status
Ultrasonix Medical Corporation Chief Executive Officer Former
Performance Technologies, Inc. Vice President and General Manager Current
Ultrasonix Medical Corporation Board of Directors Current
Ultrasonix Medical Corporation President Former
Senorx, Inc. Vice President of Global Sales and Business Development Former
Diasonics, Inc. Former
Dominican College Bachelor's Degree In Business Administration, Human Resources Management Former
Dominican College Business Administration, Human Resources Management Former

Organization Position Status
Senorx, Inc. Vice President, Finance and Cfo Current
Golden Gate University M.S. In Taxation Former
California State University B.A. In Business Administration Former

Paul Lubock . Mr. Lubock is one of our co-founders and has served as our Chief Technical Officer since October 1999 and Senior Vice President since April 2009. Mr. Lubock also served on our Board from our inception in January 1998 to December 2001 and served as our Chief Operating Officer from January 1998 to October 1999. Prior to January 1998, Mr. Lubock was the co-founder and a principal at Abacus Design & Development, a medical product development company, and the founder of Laparomed, a laparoscopic medical device company acquired by Advanced Surgical in 1994. Mr. Lubock held various positions at Laparomed, including President, Vice President, Engineering and served on its board of directors. Mr. Lubock earned his B.A. in Applied Mechanics and Engineering Science from the University of California, San Diego and his M.S. in Mechanical Engineering from the University of California, Berkeley.

Organization Position Status
Senorx, Inc. Senior Vice President and Chief Technology Officer Current
University of California, Berkeley M.S. In Mechanical Engineering Former
University of California, San Diego B.A. In Applied Mechanics and Engineering Science Former

Organization Position Status
Senorx, Inc. Vice President, Regulatory Affairs & Quality Assurance Current
ReVision Optics Vice President, Regulatory Affairs and Quality Assurance Former
California Polytechnic State University B.S. In Zoology Former

Organization Position Status
Senorx, Inc. Vice President of Manufacturing Current
Senorx, Inc. Director, Operations Former
Paratech, Inc. Production Manager Former
Coast Sign Inc Manager Former
Enthone - Omi, Inc. Distribution Manager Former

Organization Position Status
Senorx, Inc. Vice President, Sales and Marketing Current
University of Michigan M.B.A. Former

Organization Position Status
Senorx, Inc. Director, Manufacturing Engineering Current

Organization Position Status
Senorx, Inc. Director of Investor Relations Current

Organization Position Status
Senorx, Inc. Current

Organization Position Status
Senorx, Inc. Current

Organization Position Status
Senorx, Inc. Current

Organization Position Status
Senorx, Inc. Current

Organization Position Status
Senorx, Inc. Current

Organization Position Status
Universal Building Products, Inc. Chief Financial Officer Current
Alsius Corporation Chairman Current
Senorx, Inc. Chairman Current
Clarient Inc. Chairman Current
Endologix Inc. Board of Directors Current
CardioGenesis Corporation Board of Directors Current
Vivometrics Board of Directors Current
Senorx, Inc. Board of Directors Current
Ormco Corporation Vice President Former
Metrex Vice President Former
Ormco Corporation Controller Former
American Hospital Supply Corporation Former
Endologix Inc. Chairman Former
Ormco Corporation Treasurer Former
Metrex Treasurer Former
Alsius Corporation Board of Directors Former
California State University M.B.A. Former
California State University B.A. In Political Science Former

Mr. Bender was elected Chairman of the Board in July 2002. He served as President and Chief Executive Officer of the Company from May 1995 through his retirement in October 2007. He also served as President of CooperVision, the Company s contact lens subsidiary, from June 1991 to December 2004. He previously served in various operating roles beginning in October 1992. Between 1966 and June 1991, Mr. Bender held a variety of positions at Allergan, Inc. (a manufacturer of eye and skin care products), including Corporate Senior Vice President, and President and Chief Operating Officer of Herbert Laboratories, Allergan s dermatology division. Mr. Bender also serves on the Board of Directors of iScience Interventional, Inc. and their compensation committee, as well as the Board of Directors for Mission Hospital Foundation in Mission Viejo, CA.

Organization Position Status
Coopervision Technology, LLC President & CEO Current
The Cooper Companies, Inc. Chairman Current
Senorx, Inc. Board of Directors Current
Coopervision Technology, LLC Board of Directors Current
Coopervision, Inc. Chairman & CEO Former
The Cooper Companies, Inc. Chief Executive Officer Former
The Cooper Companies, Inc. President Former
Coopervision, Inc. President Former
Allergan, Inc. president Former
The Cooper Companies, Inc. Coo Former
Allergan, Inc. chief operating officer Former
Allergan, Inc. Corporate Senior Vice President Former
The Cooper Companies, Inc. Senior Vice President Operations Former
Allergan, Inc. Senior Management Positions Former
Senorx, Inc. Committee Chair for Compensation Committee Former
The Cooper Companies, Inc. Board Director Former
University of St. Thomas B.S. In History Former

Organization Position Status
De Novo Founder Current
Cartilix, Inc. Board of Directors Current
Vitreo Retinal Technologies, Inc. Board of Directors Current
Talima Board of Directors Current
Bayhill Therapeutics Board of Directors Current
Omnicell Inc. Board of Directors Current
Healthtalk, Inc. Board of Directors Current
Senorx, Inc. Board of Directors Current
Crosspoint Venture Partners General Partner Former
Crosspoint, Inc. Former
Point Biomedical Corporation Board of Directors Former
University of Chicago M.B.A. Degree Former
Iowa State University B.S. Degree In Industrial Engineering Former
University Corp. Degree In Economics Former

Organization Position Status
De Novo Ventures Managing Director Current
Senorx, Inc. Board of Directors Current
Crosspoint Venture Partners General Partner Former
University of Chicago M.B.A. Former
Iowa State University B.S.I.E. In Industrial Engineering Former
University Corp. Degree In Economics Former

Organization Position Status
Bayhill Therapeutics Board Member Current
Senorx, Inc. Board of Directors Current
Tularik, Inc. Investor Current
Omnicell Inc. Investor Current
Crosspoint Venture Partners General Partner Former
International Business Machines Corporation executive positions in sales Former
Millipore Corporation executive positions in sales Former
Point Biomedical Corporation Board Member Former
University of Chicago MBA Former

Organization Position Status
Osprey Medical, Inc. Chairman Current
V-Kardia Inc. Chairman Current
Vascular Solutions, Inc. Director Current
Senorx, Inc. Board of Directors Current
Vascular Solutions, Inc. CEO Former
Chf Solutions Inc Chief Executive Officer Former
Chf Solutions Inc Executive Chairman of the Board of Directors Former
Vascular Solutions, Inc. Chairman of the Board, Chf Solutions Former
California State University B.A. In Business Administration Former
CryoCath Technologies Inc Director Current

Organization Position Status
Tandem Diabetes Care, Inc. President and Chief Executive Officer Current
Medivation, Inc. Chairman of the Board Current
Tandem Diabetes Care, Inc. Board Member Current
DexCom, Inc. Board of Directors Current
Senorx, Inc. Board of Directors Current
Biosite Diagnostic Inc. Chairman & CEO Former
Biosite Diagnostic Inc. Chairman & CEO Former
Biosite Diagnostic Inc. President Former
Biosite Diagnostic Inc. co-founder Former
Geneohm Sciences, Inc. Former
Medivation, Inc. Board of Directors Former
Loyola University M.B.A and bachelor's degree Former

Kurt C. Wheeler has been Managing Director of Clarus Ventures since the firm's inception in 2005. He has over 25 years of direct investment and industry experience within the healthcare sector, including being a General Partner in a healthcare venture capital firm since 2000. Mr. Wheeler was founder and CEO of InControl, a publicly traded medical device company which was sold to Guidant. Prior to founding InControl he was a Principal with the Mayfield Fund focusing on healthcare investing. Mr. Wheeler began his career with Elli Lilly. Mr. Wheeler holds a B.A. from Brigham Young University, and a M.B.A. from Northwestern University. Mr. Wheeler represents Clarus Ventures on the Board of Directors of Globus Medical, Inc., Sientra, and Zogenix. In addition Mr. Wheeler is on the Board of Directors of Alsius, Cardiac Dimensions, CHF Solutions, Cryocor (NASDQ:CRYO), Hemosense (AMEX:HEM), Neuromed Pharmaceuticals, SenoRx, Somaxon Pharmaceuticals (NASDAQ:SOMX) and Xoft.

Organization Position Status
Clarus Ventures, LLC Managing Director Current
Neuromed Pharmaceuticals, Inc. Managing Director of Clarus Ventures Current
MPM Capital Limited Partnership General Partner Current
Senorx, Inc. Board of Directors Current
Neuromed Pharmaceuticals, Inc. Board of Directors Current
HemoSense, Inc. Board of Directors Current
Intraluminal Therapeutics, Inc. Board of Directors Current
Somaxon Pharmaceuticals, Inc. Board of Directors Current
Cardiac Dimensions, Inc. Board of Directors Current
Chf Solutions Inc Board of Directors Current
Xoft, Inc. Board of Directors Current
Zogenix, Inc. Board of Directors Current
Alsius Corporation Board of Directors Current
Incontrol CEO Former
Incontrol Founder Former
Mayfield Fund Principal Former
Eli Lilly and Company Former
Guidant Former
Incontrol Chairman Former
Northwestern University M.B.A. Degree Former
CryoCor, Inc. Board of Directors Current
Brigham Young University B.A. degree Former

Vickie Capps joined DJO Incorporated in July 2002 and currently serves as Executive Vice President of Finance and Chief Financial Officer. Ms. Capps has over 20 years experience in financial leadership with growing and dynamic technology companies, as well as experience in operations, planning and investor relations. Ms. Capps joins DJO Incorporated from AirFiber, a privately held provider of broadband wireless solutions, where she served as Senior Vice President, Finance and Administration and Chief Financial Officer, with responsibility for finance, legal, human resources and information technologies. Prior to that, Ms. Capps served as Vice President of Finance and Administration and CFO for Maxwell Technologies, Inc. With Maxwell, she oversaw the financial activities of the multi-division, international public company with over $100 million in revenues. During her tenure, Ms. Capps led several merger and acquisition transactions and was a key member of a new corporate executive team focusing on a new strategy, vision and business model. Prior to Maxwell, Ms. Capps served in various positions, including CFO, with Wavetek Wandel Goltermann, Inc., a multinational communications company, overseeing a growth in revenues from $58 million to over $500 million during her tenure. With Wavetek, she managed and developed over 100 finance professionals in over 25 countries and managed all legal, SEC, banking and investment banking activities for the company. Ms. Capps also served 10 years as a senior audit and accounting professional for Ernst & Young LLP. Ms. Capps is a California Certified Public Accountant. Ms. Capps received a Bachelor of Science degree in Business Administration/Accounting from San Diego State University.

Organization Position Status
DJO Incorporated Executive Vice President and Chief Financial Officer Current
DJO Incorporated Board of Directors Current
Senorx, Inc. Board of Directors Current
Maxwell Technologies, Inc. Cfo Former
Maxwell Technologies, Inc. Vice President of Finance and Administration Former
San Diego State University B.S. In Business Administration, Accounting Former

Organization Position Status
Canaan Partners General Partner Current
Northstar Neuroscience, Inc. Current Class II Director Current
Alsius Corporation Executive Compensation Current
Senorx, Inc. Board of Directors Current
Alsius Corp Board of Directors Current
Bipar Sciences, Inc Board of Directors Current
Spaltudaq Corporation Board of Directors Current
Alsius Corporation Board of Directors Current
Aperon Biosystems Board of Directors Current
Mayfield Fund Managing Director Former
Mayfield General Partner Former
Spring Ridge Ventures General Partner Former
Mayfield Fund General Partner Former
Nellcor Management Positions Former
Oculir, Inc. Board of Directors Former
ReVision Optics Board of Directors Former
Micro Therapeutics, Inc. Board of Directors Former
Northstar Neuroscience, Inc. Investor Former
Spine Wave, Inc. Investor Former
Harvard University M.B.A. Former
Harvard Business School MBA Former
Stanford University A.B. In Human Biology Former

Executive News

  • SenoRx Announces Oral Presentations Related to Its Contura(tm) MLB to be Delivered...

    Reuters - 5/26/09 - View Story

  • Digirad Names Two Veteran Healthcare Executives to Board

    Stockwatch - 5/20/09 - View Story

  • SenoRx Announces Availability of Its 2008 Annual Report On Its Newly Redesigned Website

    Reuters - 5/18/09 - View Story

advertisement
     SENO $6.77 +1.71 (33.79% )
Average Volume 41,213
Shares Outstanding 17.40M
Market Cap 117.8M
Year High 7
Year Low 2.3
Earnings Per Share -0.09
P/E Ratio -75.22
Dividend N/A
Yield N/A
advertisement
Click Here